Background: Obesity-associated inflammation is characterized by an increased abundance of macrophages (MFs) in white adipose tissue (WAT), leading to the production of inflammatory cytokines, chemokines and prostaglandins (PGs) that can cause insulin resistance. Grape powder extract (GPE) is rich in phenolic phytochemicals that possess anti-oxidant and antiinflammatory properties. Objective: We examined the ability of GPE to prevent lipopolysaccharide (LPS)-mediated inflammation in human MFs and silence the cross-talk between human MFs and adipocytes. Design: We investigated the effect of GPE pretreatment on LPS-mediated activation of mitogen activated protein kinases (MAPKs), nuclear factor kappa B (NF-kB) and activator protein-1 (AP-1), and induction of inflammatory genes in human MFs (that is, differentiated U937 cells). In addition, we determined the effect of GPE pretreatment of MFs on inflammation and insulin resistance in primary human adipocytes incubated with LPS-challenged MF-conditioned medium (MF-CM). Methods and Results: Pretreatment of MFs with GPE attenuated LPS-induction of inflammatory cytokines, such as tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6) and IL-1b; chemokines, such as IL-8 and interferon-g inducible protein-10 (IP-10); and a marker of PG production, cyclooxygenase-2 (COX-2). Grape powder extract also attenuated LPS activation of MAPKs, NF-kB and AP-1 (c-Jun), as evidenced by decreased (1) phosphorylation of c-Jun NH 2 -terminal kinase (JNK) and p38; (2) degradation of IkBa and activation of an NF-kB reporter construct; and (3) phosphorylation of c-Jun and Elk-1. Using LPSchallenged MF-CM, GPE pretreatment attenuated MF-mediated inflammatory gene expression, activation of an NF-kB reporter and suppression of insulin-stimulated glucose uptake in human adipocytes.
Introduction
The incidence of obesity is increasing worldwide, and due to its associated comorbidities is becoming a major public health concern.
1,2 Obesity is considered a low-grade, chronic inflammatory disease characterized by macrophage (MF) infiltration into the white adipose tissue (WAT). 3, 4 Secretion of proinflammatory mediators from activated MFs exacerbates WAT inflammation, thereby contributing to the pathogenesis of obesity-related diseases, such as atherosclerosis, type 2 diabetes and hypertension. 5 Indeed, obese individuals present with increased serum and tissue levels of inflammatory markers, such as tumor necrosis factor-a (TNF-a), interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1). 6, 7 Notably, several studies reported that MFs are the primary source for proinflammatory cytokine production in WAT and may be recruited to WAT via MCP-1. [8] [9] [10] [11] [12] Furthermore, numerous animal studies have demonstrated the importance of MFs in inflammationinduced insulin resistance. 11, [13] [14] [15] High blood levels of lipopolysaccharide (LPS) are indicative of metabolic endotoxemia 16 , and activate immune cells, including MFs. Lipopolysaccharide activates toll-like receptors and co-receptors (cluster of differentiation (CD)-14, myeloid differentiation (MD)-2) on these cells, triggering an inflammatory signaling cascade involving mitogen activated protein kinases (MAPKs), nuclear factor kappa B (NF-kB), Elk-1 and activator protein-1 (AP-1). These activated proteins induce the transcription of many proinflammatory genes, including those for cytokines, chemokines and other immunomodulators that adversely affect WAT, triggering inflammation and insulin resistance. Notably, diet-induced obesity increases plasma levels of LPS in mice, which contributes to obesity, inflammation and insulin resistance in these animals. 16 Therefore, reducing chronic inflammatory cytokine production through inhibition of MAPK and NF-kB signaling pathways in MFs may prevent obesityassociated inflammation and insulin resistance. Recent attention has focused on the anti-inflammatory properties of bioactive food components. As fruits and fruit extracts are abundant in bioactive components, such as polyphenols, they possess an immense potential to prevent the development of obesity-related inflammation and insulin resistance. Grapes are one of the most widely consumed fruits in the world. 17 They contain high concentrations of polyphenols that have been shown in numerous in vivo and in vitro studies to exert anti-inflammatory and anti-oxidant effects. For example, grape seed procyanidin modulated the inflammatory response in endotoxin-stimulated RAW264 MFs by inhibiting NF-kB. 18 In addition, oligomerized grape seed polyphenols have been shown to reduce NF-kB transcriptional activity and activation of extracellular signal-related kinase (ERK) in a coculture of murine adipocytes and MFs. 17 However, the ability of grape powder extract (GPE) to prevent inflammation in human MFs and block inflammation and insulin resistance in human adipocytes treated with MF-conditioned media (CM) is unknown. Furthermore, the potential anti-inflammatory mechanisms of action of GPE are unknown. In this study, we hypothesized that GPE would prevent LPS-mediated activation of MAPKs, NF-kB, Elk-1 and AP-1, and subsequent induction of inflammatory genes in human MFs. Furthermore, we speculated that GPE would decrease inflammation and insulin resistance in primary cultures of human adipocytes incubated with LPS-challenged MF-CM.
Materials and methods

Materials
All cell culture-ware were purchased from Fisher Scientific (Norcross, GA, USA). Fetal bovine serum (FBS) was purchased from Hyclone (Logan, UT, USA). The RPMI (Roswell Park Memorial Institute) 1640 medium was purchased from American Type Culture Collection (Manassas, VA, USA). Lipopolysaccharide was purchased from Sigma-Aldrich (St. Louis, MO, USA). Tri Reagent was purchased from Molecular Research Center (Cincinnati, OH, USA). Genespecific primers were purchased from Applied Biosystems (Foster City, CA, USA). Polyclonal antibody for antiglyceraldehyde-3-phosphate dehydrogenase (GAPDH) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-phospho (Thr180/Typ182) p38 antibody was purchased from BD Bioscience Pharmingen (San Jose, CA, USA). Anti-phospho (Thr183/Tyr185) and total c-jun NH 2 -terminal kinase (JNK), anti-phospho (Thr180/Tyr182) and total p38, anti-phospho (Ser63) c-Jun and total c-Jun and anti-phospho (Ser383) Elk-1 antibodies were purchased from Cell Signaling Technologies (Beverly, MA, USA). Immunoblotting buffers and precast gels were purchased from Invitrogen (Carlsbad, CA, USA). Western Lightning chemiluminescence substrate was purchased from Perkin Elmer Life Science (Boston, MA, USA). All other reagents and chemicals were purchased from Sigma-Aldrich unless otherwise stated. 21 The powder was extracted to remove the sugars (90% w/w) using a Diaion HP-20 anion resin column and eluted from the column using methanol, and subsequently lyophilized as per the protocol provided by CTGC. Grape powder extract was dissolved in dimethyl sulfoxide to make a stock solution of 100 mg ml
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À1
concentration and stored at À20 1C. Stock concentrations were diluted immediately before use.
Analysis of GPE polyphenols
Several polyphenols in GPE were determined using reverse phase high-performance liquid chromatography (HPLC) as previously described.
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RNA isolation and real-time quantitative PCR After treatment, cells were collected and total RNA was isolated using Tri Reagent according to the manufacturer's protocol. For real time quantitative PCR, 2.0 mg total RNA was converted into first strand complementary DNA using Applied Biosystems' High-Capacity cDNA Archive Kit. The quantitative PCR was performed in an Applied Biosystems 7500 FAST Real Time PCR System using TaqMan Gene Expression Assays. To account for possible variation related to complementary DNA input or the presence of PCR inhibitors, the endogenous reference gene GAPDH was simultaneously quantified for each sample, and data were normalized accordingly.
Analysis of secretion of IL-6 and interferon-g inducible protein-10 (IP-10) through multiplex cytokine assay The concentrations of IL-6 and IP-10 were determined using the BioPlex Suspension Array System from Bio-Rad (Hercules, CA, USA) following the manufacturer's protocol.
Immunoblotting
Immunoblotting was conducted as previously described. 19 
Transient transfections of MFs
Macrophages were transiently transfected with the NF-kBresponsive luciferase (luc) reporter construct pNFkB luc (Strategene, La Jolla, CA, USA) using the Amaxa (Cologne, Germany) nucleofector. A total of 1.25 Â 10 6 cells from a 60-mm plate were collected by scraping with 10 mmol l À1 ethylenediaminetetraacetic acid and resuspended in 100 ml of nucleofector solution (Amaxa) and mixed with 2 mg of pNFkB luc and 25 ng pRL-CMV for each sample. Electroporation was performed using the W-005 nucleofector program (Amaxa). Cells were replated in 96-well plates after 10-min recovery in RPMI medium. After 24 h, transfected cells were pretreated with 10 mg ml À1 GPE for 1 h and treated with 100 ng ml À1 LPS for 8 h. This 8-h treatment with LPS was chosen on the basis of the results of a pilot time course study (data not shown). Firefly luciferase activity was measured using the Dual-Glo luciferase kit and normalized to Renilla luciferase activity from the co-transfected control pRL-CMV vector. All luciferase data are presented as a ratio of firefly luciferase to Renilla luciferase activity.
MF-CM experiments in primary human adipocytes
Conditioned medium was collected from MF cultures pretreated for 1 h with or without 10, 30, 60 or 100 mg ml
À1
GPE followed by treatment for 3 h with 100 ng ml À1 LPS.
The MF-CM obtained from each experiment was pooled and stored at À80 1C until used. Distinct pools were used for each experiment. For RNA isolation and quantitative PCR experiments, primary human adipocytes were seeded in 35-mm dishes at a density of 0.5 Â 10 6 per dish and allowed to differentiate for 6 days. On day 6, medium was changed and cells were incubated in 1 ml of adipocyte medium-1. After 24 h, the following were added to the cultures (1) fresh adipocyte medium-1, (2) fresh RPMI, (3) LPS-challenged MF-CM or (4) LPS-challenged MF-CM pretreated with GPE. The amount and duration of MF-CM treatment varied depending on the outcome measured.
Transient transfections of primary human adipocytes
Primary human adipocytes were transiently transfected with the NF-kB-responsive luciferase (luc) reporter construct pNFkB luc (Strategene) using the Amaxa nucleofector. On day 6 of differentiation, 1.2 Â 10 6 cells from a 60-mm plate were trypsinized and resuspended in 100 ml of nucleofector solution (Amaxa) and mixed with 1 mg of pNFkB luc and 25 ng pRL-CMV for each sample. Electroporation was performed using the V-33 nucleofector program (Amaxa). Cells were replated in 96-well plates after 10-min recovery in calcium-free RPMI medium. After 24 h, transfected cells were treated for 24 h with GPE-pretreated or LPS-challenged MF-CM as described above. This 24-h treatment with LPS-challenged MF-CM was chosen on the basis of the results of a pilot time course study (data not shown). Firefly and Renilla luciferase activity were measured as described above for transfected MFs.
2-[3H]deoxy-glucose uptake
Primary human adipocytes were incubated on day 11 or 12 with low glucose (5 mmol l
À1
) and insulin (20 pmol l
)-containing media for 24 h. Cultures were then treated with LPS-challenged MF-CM or CM from LPS-challenged MFs pretreated with GPE for 24 h. Basal and insulin-stimulated 2-[3H]deoxy-glucose levels were measured as described previously. 19 
Statistical analysis
Statistical analyses were performed for data in Figure 2a by testing the main effects of GPE dose (À or þ ) and LPS (À or þ ) and their interaction (GPE Â LPS) using two-way analysis of 
Results
Polyphenol content of GPE Initial analysis of our GPE by reverse phase HPLC revealed a high concentration of quercetin-3-glucoside (B8.0%, Figure 1 ). Other polyphenols included catechins (2.3%), epicatechin (1.9%), gallic acid (1.4%), rutin (1.2%) and resveratrol (0.53%).
GPE decreases LPS-induced inflammatory gene expression and protein secretion
To determine the extent to which GPE attenuated markers of inflammation, MFs were pretreated for 1 h with GPE (0, 10, 30 or 100 mg ml
À1
) and stimulated with 100 ng ml À1 LPS for 3 h. The treatment with LPS markedly increased the expression of IL-6, IL-8, IL-1b and TNF-a, and GPE decreased the induction of these genes in a dose-dependent manner (Figure 2a) . LPS-induced IP-10 was blocked by 10 mg ml À1 GPE, and cyclooxygenase-2 (COX-2) induction was attenuated to the same extent with 10 and 30 mg ml À1 GPE, and blocked by 100 mg ml À1 GPE (Figure 2a ). In the absence of LPS, GPE alone did not affect inflammatory gene expression ( Figure 2a) . As LPS-mediated induction of IP-10 and IL-6 was decreased to the greatest extent by GPE, we measured their secretion in the CM. Interleukin-6 secretion was robustly increased by LPS, whereas IP-10 was only slightly increased ( Figure 2b ). The LPS-mediated IL-6 secretion was modestly decreased by 30 mg ml À1 GPE, whereas IP-10 secretion was blocked by GPE (Figure 2b ). These differences may be due to the level of secretion induced by LPS. No visual cytotoxic effects of GPE were observed (for example, no floating cells or changes in cell morphology were observed).
GPE decreases LPS-mediated activation of MAPK
Given the important role of MAPK in activating transcription factors that induce inflammatory gene expression, we examined the effects of GPE on the phosphorylation of MAPK in MFs. Marcophages were pretreated for 1 h with GPE (0, 30, 60 or 100 mg ml
À1
) and stimulated with 100 ng ml À1 LPS for 30 min. Grape powder extract attenuated the LPS-mediated phosphorylation of JNK and p38 in a dosedependent manner (Figure 3 ). In the absence of LPS, GPE alone did not affect phosphorylation of JNK or p38. Grape powder extract did not attenuate LPS-mediated phosphorylation of ERK (data not shown).
GPE decreases LPS-mediated NF-kB, AP-1 and Elk-1 activation
To determine the extent to which GPE prevented LPS activation of the inflammatory transcription factors: NF-kB, AP-1 and Elk-1, IkBa degradation, c-Jun and Elk-1 phosphorylation and NF-kB reporter activity were determined in MFs. Pretreatment of MFs with 100 mg ml À1 GPE attenuated LPS- Figure 1 Reverse phase high-performance liquid chromatography (HPLC) of grape powder extract (GPE) indicates that quercetin-3-glucoside (8.0%) is a major component of GPE. Other polyphenols include catechins (2.3%), epicatechin (1.9%), gallic acid (1.4%), rutin (1.2%), and resveratrol (0.53%).
Polyphenol-rich GPE attenuates inflammation A Overman et al phosphorylation. In the absence of LPS, GPE had no effect on IkBa degradation, but slightly increased phosphorylation of c-Jun and Elk-1 (Figure 4a ). Finally, 10 mg ml À1 GPE and 0.1 mM Rosiglitazone (that is, BRL, a positive control) blocked NF-kB reporter activation by LPS (Figure 4b ).
GPE pretreatment of MFs decreases MF-CM-mediated inflammation and insulin resistance in human adipocytes
Several studies have reported cross-talk between murine MFs and adipocytes; that is, activated MFs can inflame adipocytes and vice-versa. 23 Therefore, we hypothesized that GPE pretreatment of LPS-treated MFs would prevent MF-CM-mediated inflammation and insulin resistance in human adipocytes. Consistent with our hypothesis, 30 mg ml 
Discussion
In this study, we demonstrated that GPE attenuated LPS-induced expression of IL-6, IL-8, IL-1b, IP-10, TNF-a immunoblotted and probed with phospho-(P) or non-P specific antibodies for IkBa, c-Jun, Elk-1 or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Data represent at least two independent experiments. (b) Cultures were pretreated with 10 mg ml À1 GPE or 0.1 mM BRL (Rosiglitazone) for 1 h and then treated with 10 ng ml À1 LPS for 8 h. NF-kB reporter activity was measured using a luciferase assay. NF-kB levels for the LPS þ BRL (Rosiglitazone) treatment were non-detectable (ND). Means ( ± s.e.; n ¼ 5-6) without a common letter differ, Po0.05. Data represent three independent experiments.
Polyphenol-rich GPE attenuates inflammation A Overman et al and COX-2, and subsequent secretion of IL-6 and IP-10 in human MFs. Grape powder extract also attenuated LPS activation of JNK and p38, and that of the transcription factors: NF-kB, AP-1 (that is, c-Jun) and Elk-1. Furthermore, we showed that GPE decreased inflammatory gene expression (that is, IL-6, IL-8, IL-1b and MCP-1) and NF-kB activity, and improved insulin-stimulated glucose uptake in human adipocytes treated with LPS-challenged MF-CM. Taken together, these findings demonstrate that GPE inhibits LPSmediated activation of inflammatory MAPKs and transcription factors that induce inflammatory gene expression and protein secretion in cultures of human MFs. This suppression of inflammatory protein secretion by GPE probably contributed to the decreased ability of CM, from LPS-stimulated MFs, to cause inflammation and insulin resistance in human adipocytes. On the basis of these data, we propose that GPE directly attenuates LPS activation of MAPKs, NF-kB and AP-1 in MFs, thereby preventing the induction and secretion of inflammatory cytokines (for example, IL-6) and chemokines (that is, IP-10). This decreased production of inflammatory mediators prevents MFs from causing inflammation and insulin resistance by attenuating the activation of NF-kB in adipocytes. Consistent with these data, increased levels of LPS have been found in the plasma of high-fat fed obese mice, 16 which contributes to inflammation and insulin resistance. Lipopolysaccharide activates MAPKs, NF-kB and AP-1, increasing the release of inflammatory cytokines and chemokines. 18, 24, 25 In obesity, the increased production of these inflammatory mediators originates mainly from infiltrating MFs in WAT. 26, 27 Macrophage-secreted factors have been shown to increase inflammation and decrease insulinstimulated glucose uptake in murine adipocytes. 13, 28 Consistent with these findings, we found that LPS increased the activation of MAPKs, NF-kB and AP-1 in human MFs, increasing their capacity to cause inflammation and insulin resistance in primary human adipocytes. Several grape products have been shown to reduce markers of inflammation or oxidative stress associated with cardiovascular disease in vivo, ex vivo and in vitro. 29, 30 For example, consumption of red grape juice by hemodialysis patients, who suffer from hemodialysis-induced oxidative stress, reduced plasma levels of oxidized low-density lipoprotein and ex vivo neutrophil NAPDH oxidase activity. 31 Similarly, consumption of red grape juice decreased markers of oxidative stress in healthy adults. 32 Consumption of GPE by adult women decreased the levels of plasma TNF-a and urinary F2 iosoprostanes, markers of inflammation and oxidative stress, respectively. 33 Similarly, adults consuming red wine had lower urinary levels of prostaglandin F-2a levels and higher plasma levels of polyphenols compared with those consuming white wine or no-wine controls. 34 Salt-sensitive, hypertensive Dahl rats supplemented with GPE had decreased cardiac oxidative damage and plasma levels of IL-6 and TNFa compared with unsupplemented control rats. 21 Zucker rats fed a high-fat diet supplemented with grape seed procyanidins had lower plasma levels of C-reactive protein and lower WAT messenger RNA levels of C-reactive protein, TNF-a and IL-6 compared with high fat-fed control rats. 35 Apolipoprotein E deficient mice, who suffer from atherosclerosis and oxidative stress, supplemented with GPE had a lower incidence of atherosclerotic plaque formation and decreased markers of oxidative stress compared to controls. 36 Furthermore, consumption of GPE by apolipoprotein E-deficient mice decreased the capacity of their peritoneal MFs to oxidize low-density lipoprotein. Consistent with these data, grape seed proanthocyanidin supplementation to cholesterol-fed hamsters decreased Polyphenol-rich GPE attenuates inflammation A Overman et al MF-mediated, aortic foam cell development by 50% compared with the unsupplemented controls. 37 In vitro, grape seed procyanidins decreased cholesterol and triglyceride accumulation in MF-derived foam cells. 38 In addition, human MF (THP-1 cell line) and adipocytes (SGBS cell line) treated with grape seed procyanidins had reduced expression of IL-1 and MCP-1 and decreased activation of NF-kB after stimulation with LPS or TNF-a, respectively.
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Consistent with these findings, our data show that GPE attenuates LPS-mediated inflammatory gene expression in MFs, possibly by decreasing activation of JNK, p38, c-Jun, Elk-1 or NF-kB. As grapes contain a wide array of phytochemicals, specific bioactive components responsible for the anti-inflammatory properties of grapes or GPE remain to be elucidated. Two promising candidates in grapes are resveratrol and quercetin that, on the basis of our reverse phase HPLC analysis, were found to be present in our GPE. For example, resveratrol attenuated the phagocytosis of bacteria by MFs through decreased NF-kB activation 40 and suppressed monocyte adhesion to human umbilical vein endothelial cells. 41 Furthermore, quercetin reduced the levels of inflammatory markers in LPS-treated U937-derived MFs 42 and suppressed the degradation of IkBa and the phosphorylation of p38 and Akt in LPS-stimulated bone marrow-derived MFs. 43 One potential mechanism by which GPE may block inflammation is by increasing peroxisome proliferatoractivated receptor-g (PPAR-g) expression or activation. Peroxisome proliferator-activated receptor-g has been described as a general negative regulator of MF activation, and has been implicated in improving muscle and hepatic insulin sensitivity, and in preventing inflammation. Peroxisome proliferator-activated receptor-g agonists, such as thiazolidinediones, reduce inflammatory gene expression in MF. 44 When administered before the onset of inflammation, thiazolidinediones exhibit beneficial effects on experimental models of inflammation, such as colitis, [45] [46] [47] [48] [49] [50] atherosclerosis, [51] [52] [53] [54] asthma, [55] [56] [57] psoriasis, 58 myocarditis 59, 60 and allergic encephalomyelitis. 61, 62 In addition, anthocyanins, such as cyanidin-3-O-b-glucoside, have also been shown to enhance the expression and transcriptional activities of PPAR-g in MF. 63, 64 Although the underlying mechanisms are not fully elucidated, it has been suggested that PPAR-g activation exerts its anti-inflammatory function by trans-repressing the NF-kB and MAPK pathways. 65, 66 Thus, GPE may be attenuating LPS-mediated activation of NF-kB and MAPKs by acting as a PPAR-g agonist. Studies are underway in our laboratory to determine the extent to which phytochemicals in our GPE, such as resveratrol and quercetin, contribute to the anti-inflammatory and insulinsensitizing properties of GPE. Other polyphenols in GPE, such as anthocyanins and flavanols, may also decrease inflammation.
